Point Of Care Hiv Nat Diagnostic And/Or Supplemental Test
QSV · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.3957
Classification
FDA Product Code
QSV
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.3957
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
Human immunodeficiency virus (HIV) Point of Care nucleic acid diagnostic and supplemental tests are prescription devices for the qualitative detection of HIV nucleic acid in human body fluids or tissues.